688399 碩世生物
按盤價 
67.620 +1.540 (+2.331%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.170 | -10.408 | 57.894 | 56.807 | 61.040 |
| 總資產報酬率 ROA (%) | 1.009 | -8.498 | 43.572 | 41.309 | 47.760 |
| 投入資產回報率 ROIC (%) | 1.072 | -9.782 | 53.923 | 52.149 | 41.602 | 邊際利潤分析 |
| 銷售毛利率 (%) | 70.927 | 63.912 | 60.616 | 69.132 | 77.590 |
| 營業利潤率 (%) | 44.055 | -90.545 | 38.840 | 49.133 | 55.355 |
| 息稅前利潤/營業總收入 (%) | 39.002 | -105.007 | 38.025 | 48.281 | 54.895 |
| 淨利潤/營業總收入 (%) | 43.973 | -92.716 | 33.026 | 42.029 | 47.110 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 7.384 | 57.415 | 114.612 | 95.566 | 94.635 |
| 價值變動淨收益/利潤總額(%) | 5.801 | -3.914 | 2.418 | 2.116 | 2.003 |
| 營業外收支淨額/利潤總額(%) | 0.052 | 2.825 | -0.514 | -0.225 | -0.210 | 償債能力分析 |
| 流動比率 (X) | 6.277 | 7.447 | 3.977 | 2.967 | 3.407 |
| 速動比率 (X) | 6.047 | 7.189 | 3.724 | 2.675 | 3.095 |
| 資產負債率 (%) | 14.581 | 12.833 | 22.753 | 27.516 | 26.921 |
| 帶息債務/全部投入資本 (%) | 6.692 | 2.771 | 1.021 | 4.917 | -- |
| 股東權益/帶息債務 (%) | 1,342.502 | 3,372.064 | 9,250.397 | 1,855.366 | 4,103.818 |
| 股東權益/負債合計 (%) | 585.835 | 679.242 | 339.502 | 263.420 | 271.455 |
| 利息保障倍數 (X) | -7.684 | 8.876 | -61.704 | -65.049 | -159.513 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 90.256 | 300.336 | 29.483 | 31.703 | 0.000 |
| 存貨周轉天數 (天) | 336.529 | 408.401 | 40.182 | 84.872 | 0.000 |
| 備註： | 即時報價更新時間為 28/06/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
